Immune signatures of checkpoint inhibitor-induced autoimmunity—A focus on neurotoxicity.

MLA

Müller-Jensen, Leonie, et al. “Immune Signatures of Checkpoint Inhibitor-Induced Autoimmunity—A Focus on Neurotoxicity.” Neuro-Oncology, vol. 26, no. 2, Feb. 2024, pp. 279–94. EBSCOhost, https://doi.org/10.1093/neuonc/noad198.

APA

Müller-Jensen, L., Schulz, A. R., Mei, H. E., Mohr, R., Ulrich, C., Knape, P., Frost, N., Frischbutter, S., Kunkel, D., Schinke, C., Roque, L. G., Maierhof, S. K., Nickel, F. T., Heinzerling, L., Endres, M., Boehmerle, W., Huehnchen, P., & Knauss, S. (2024). Immune signatures of checkpoint inhibitor-induced autoimmunity—A focus on neurotoxicity. Neuro-Oncology, 26(2), 279–294. https://doi.org/10.1093/neuonc/noad198

Chicago

Müller-Jensen, Leonie, Axel R Schulz, Henrik E Mei, Raphael Mohr, Claas Ulrich, Philipp Knape, Nikolaj Frost, et al. 2024. “Immune Signatures of Checkpoint Inhibitor-Induced Autoimmunity—A Focus on Neurotoxicity.” Neuro-Oncology 26 (2): 279–94. doi:10.1093/neuonc/noad198.